Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2002
06/20/2002WO2002004600A3 Novel compounds
06/20/2002WO2002003911A8 Prevention and treatment of alzheimer's disease
06/20/2002WO2001098542A3 Universal collection medium
06/20/2002WO2001098358A3 Compositions for identification and isolation of stem cells
06/20/2002WO2001094541A3 Human mesenchymal progenitor cell
06/20/2002WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS
06/20/2002WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer
06/20/2002WO2001090139A3 A ligand for enhancing oral and cns delivery of biological agents
06/20/2002WO2001088104A3 Neural progenitor cell populations
06/20/2002WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path
06/20/2002WO2001085942A3 Cytoskeleton-associated proteins
06/20/2002WO2001083524A3 Rna metabolism proteins
06/20/2002WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same
06/20/2002WO2001073086A3 Method for genetically modifying a plant
06/20/2002WO2001072961A3 Novel compounds
06/20/2002WO2001068851A3 Polypeptides and nucleic acids encoding same
06/20/2002WO2001060857A3 Compositions useful for regulating parkin gene activity
06/20/2002WO2001053487A3 Human sperm specific lysozyme-like proteins
06/20/2002WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer
06/20/2002WO2001044445A8 Human lyases and associated proteins
06/20/2002WO2000077233A9 Complement-resistant non-mammalian dna viruses and uses thereof
06/20/2002WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof
06/20/2002WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
06/20/2002WO2000061596A8 50 human secreted proteins
06/20/2002WO2000050596A9 14273 receptor, a novel g-protein coupled receptor
06/20/2002US20020078474 Genetic engineering of syringyl-enriched lignin in plants
06/20/2002US20020077468 Corticotropin-releasing factor2 receptors
06/20/2002US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis
06/20/2002US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
06/20/2002US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects
06/20/2002US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering
06/20/2002US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders
06/20/2002US20020077307 Methods for regulating gene expression
06/20/2002US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease
06/20/2002US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis
06/20/2002US20020077270 Nucleic acids, proteins, and antibodies
06/20/2002US20020076816 Generating preferential stemm cells; obtain cells, expose to activated egg extract, culture, monitor differentiation
06/20/2002US20020076814 Method of using fish plasma components for tissue culture
06/20/2002US20020076813 Stabilizing diluent for polypeptides and antigens
06/20/2002US20020076812 Generation of pluripotent cells; obtain cells, incubate with modulator, monitor gene expression in cells
06/20/2002US20020076811 Mammalian artificial chromosomes
06/20/2002US20020076810 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders
06/20/2002US20020076808 Use of suppressor tRNA's to regulate cytotoxicity during the production of recombinant gene products
06/20/2002US20020076801 AAV DNA comprising helper virus sequences
06/20/2002US20020076796 2786, a novel human aminopeptidase
06/20/2002US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
06/20/2002US20020076791 Cultured rodent cells; for use in generation of heterologous proteins
06/20/2002US20020076787 Increasing the replicative capacity of normally quiescent cells, such as normal somatic cells, by transient immortalization or transient telomerization, to produce cells suitable for gene therapy
06/20/2002US20020076783 Plants and plants cells expressing histidine tagged intimin
06/20/2002US20020076777 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
06/20/2002US20020076763 Production of a multimeric protein by cell fusion method
06/20/2002US20020076761 Polypeptides for use in human therapeutics and diagnostics
06/20/2002US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
06/20/2002US20020076750 Peptide for use as tools in human therapeutics and diagnostics
06/20/2002US20020076747 Method for expanding embryonic stem cells in serum-free culture
06/20/2002US20020076744 Optoinjection methods
06/20/2002US20020076730 Cell culltures for use in detcetion, evaluation and treatment of bone disorders
06/20/2002US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain
06/20/2002US20020076445 Eukaryotic cells and method for preserving cells
06/20/2002US20020076407 Method for selectively stimulating proliferation of t cells
06/20/2002US20020076406 Multivalent target binding protein
06/20/2002US20020076403 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
06/20/2002US20020076400 Adipose-derived stem cells and lattices
06/20/2002US20020076395 Modified adipose tissue and related implants and methods
06/20/2002DE10108264A1 Stammzellen, Verfahren zu deren Expansion in vitro sowie deren Verwendung Stem cells, method for their expansion in vitro and the use thereof
06/20/2002DE10063179A1 Detecting tumor cells and their precursors in cervical smears, by simultaneous detection of two markers, suitable for automation and providing an objective diagnosis
06/20/2002DE10062422A1 Verwendung von Acetyl-CoA Carboxylase zum Identifizieren von insektizid wirksamen Verwendung Use of acetyl-CoA carboxylase for identifying insecticidally effective use
06/20/2002DE10061704A1 Verfahren und Vorrichtung zur Herstellung von biologischem Gewebe in einer Wachstumskammer Method and apparatus for production of biological tissue in a growth chamber
06/20/2002DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants
06/20/2002CA2432736A1 Silenced anti-cd28 antibodies and use thereof
06/20/2002CA2431644A1 Compositions and methods for the release of nucleic acid molecules from solid matrices
06/20/2002CA2431210A1 Novel human kinases and uses thereof
06/20/2002CA2430906A1 Proteins associated with cell growth, differentiation, and death
06/20/2002CA2430905A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002CA2430901A1 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/20/2002CA2430896A1 Mhc class i associated peptides for prevention and treatment of tuberculosis
06/20/2002CA2430736A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002CA2430297A1 Interferon-alpha induced gene
06/20/2002CA2429952A1 Method for generating immortal dendritic cell lines
06/20/2002CA2429401A1 Method for in vitro culture of ovarian follicles
06/20/2002CA2428216A1 Secreted proteins
06/20/2002CA2365494A1 Lawsonia intracellularis vaccine
06/19/2002EP1215497A1 Diagnostics for transmissible spongiform encephalopathy
06/19/2002EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2
06/19/2002EP1215280A1 Method for in vitro culture of ovarian follicles
06/19/2002EP1215214A1 Novel polypeptide
06/19/2002EP1214952A1 Materials for culturing cardiovascular tissues and method of tissute regeneration
06/19/2002EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products
06/19/2002EP1214867A2 System and method for microwave cell lysing of small samples
06/19/2002EP1214593A2 Screening for compounds modulating mitochondrial proton leak
06/19/2002EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby
06/19/2002EP1214452A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes
06/19/2002EP1214444A2 Whole cell assay for cathepsin k
06/19/2002EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
06/19/2002EP1214440A2 Sequence-specific dna recombination in eukaryotic cells
06/19/2002EP1214437A1 Use of lentiviral vectors for antigen presentation in dendritic cells
06/19/2002EP1214436A2 Wheat dp proteins and uses thereof
06/19/2002EP1214435A2 Seed-preferred promoter from maize
06/19/2002EP1214427A2 26176, a novel calpain protease and uses thereof
06/19/2002EP1214422A1 Phosphatases which activate map kinase pathways
1 ... 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 ... 1827